Johnson & Johnson - Jul 2, 2021 Form 4 Insider Report for CVRx, Inc. (CVRX)

Role
10%+ Owner
Signature
Johnson & Johnson By: /s/ Matthew Orlando, Secretary
Stock symbol
CVRX
Transactions as of
Jul 2, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 04:59 PM
Previous filing
Jun 29, 2021
Next filing
Nov 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVRX Common Stock Conversion of derivative security +3.5M 3.5M Jul 2, 2021 By Johnson & Johnson Innovation - JJDC, Inc. F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVRX Series D-2 Preferred Stock Conversion of derivative security $0 -4.03M -100% $0.00* 0 Jul 2, 2021 Common Stock 102K By Johnson & Johnson Innovation - JJDC, Inc. F1, F2
transaction CVRX Series E-2 Preferred Stock Conversion of derivative security $0 -6.45M -100% $0.00* 0 Jul 2, 2021 Common Stock 163K By Johnson & Johnson Innovation - JJDC, Inc. F1, F2
transaction CVRX Series F-2 Preferred Stock Conversion of derivative security $0 -7.59M -100% $0.00* 0 Jul 2, 2021 Common Stock 192K By Johnson & Johnson Innovation - JJDC, Inc. F1, F2
transaction CVRX Series G Preferred Stock Conversion of derivative security $0 -48.1M -100% $0.00* 0 Jul 2, 2021 Common Stock 3.04M By Johnson & Johnson Innovation - JJDC, Inc. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock.
F2 These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.